SCHEMBL1279253

SCHEMBL1279253

CC(C)c1cc(=O)n2nc(-c3ccc(Cl)cc3)c(-c3ccccc3)c2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLAT P00750 1/20 0.41
MAPT P10636 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
ARF6 P62330 3/20 0.38
GAA P10253 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
LMNA P02545 2/20 0.38
PSD A5PKW4 2/20 0.37
TP53 P04637 2/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
PARP1 P09874 1/20 0.37
KDM5B Q9UGL1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13516130 0.87 MAT2A (0.47) PLATMAPTKDM4ENPSR1LMNA
SCHEMBL15926320 0.82 PLAT (0.43) PLATMAPTKDM4EMEN1KMT2A
SCHEMBL1614788 0.81 HPGD (0.43) PLATMAPTKDM4EMEN1KMT2A
SCHEMBL1279349 0.81 MEN1 (0.43) PLATMAPTKDM4EMEN1KMT2A
SCHEMBL1279260 0.80 ARF6 (0.45) PLATMAPTKDM4EMEN1KMT2A
SCHEMBL1279407 0.78 MAT2A (0.49) MAPTKDM4EMEN1KMT2AGAA
SCHEMBL1278904 0.77 POLB (0.45) PLATKDM4EMEN1KMT2AARF6
SCHEMBL19926513 0.76 MEN1 (0.46) PLATMAPTKDM4EMEN1KMT2A
SCHEMBL19084479 0.75 PSD (0.48) MAPTMEN1KMT2AARF6LMNA
SCHEMBL1614861 0.75 ARF6 (0.39) PLATMAPTMEN1KMT2AARF6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 PLAT 1286/4885MAPT 1089/4885KDM4E 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.